EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation
Authors
Keywords
SW480 cells, Colon, Flow cytometry, Blood, Prostate gland, HT29 cells, Polymers, Metastasis
Journal
PLoS One
Volume 11, Issue 10, Pages e0163705
Publisher
Public Library of Science (PLoS)
Online
2016-10-07
DOI
10.1371/journal.pone.0163705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
- (2015) Hara Polioudaki et al. BMC CANCER
- Genomic profiling of breast cancers
- (2015) Christina Curtis CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
- (2015) Stéphane Terry et al. Oncotarget
- Twist1 correlates with poor differentiation and progression in gastric adenocarcinomaviaelevation of FGFR2 expression
- (2015) Dong-Yuan Zhu WORLD JOURNAL OF GASTROENTEROLOGY
- EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
- (2015) Maria J. Serrano et al. Oncotarget
- The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
- (2014) Rhonda L. Bitting et al. CANCER AND METASTASIS REVIEWS
- Biology, detection, and clinical implications of circulating tumor cells
- (2014) S. A. Joosse et al. EMBO Molecular Medicine
- Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
- (2014) Francesca Bedussi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer
- (2014) Simona Carnio et al. Expert Review of Anticancer Therapy
- HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
- (2014) Danilo Ranieri et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer
- (2014) Paola Gazzaniga et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor Vasculature Is Regulated by FGF/FGFR Signaling-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRs
- (2014) Pierre Fons et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
- (2014) Lorena Alonso-Alconada et al. Molecular Cancer
- Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
- (2014) Marta Pestrin et al. Molecular Oncology
- Biosensors for the Detection of Circulating Tumour Cells
- (2014) Clotilde Costa et al. SENSORS
- Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
- (2014) Laura Muinelo-Romay et al. Cancers
- Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
- (2013) Yibin Kang et al. CANCER CELL
- Context-dependent adaption of EpCAM expression in early systemic esophageal cancer
- (2013) C Driemel et al. ONCOGENE
- Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
- (2013) Ramdane Harouaka et al. PHARMACOLOGY & THERAPEUTICS
- Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
- (2013) Tiewei Cheng et al. PLoS One
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
- (2013) L. Zhang et al. Science Translational Medicine
- Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
- (2012) Agnieszka Martowicz et al. BMC CANCER
- ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas
- (2012) E Colas et al. ONCOGENE
- Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
- (2012) Jorge Barbazán et al. PLoS One
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Circulating tumor cells as emerging tumor biomarkers in breast cancer
- (2011) Evi S. Lianidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
- (2011) Stephen D. Mikolajczyk et al. Journal of Oncology
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- Molecular Biomarker Analyses Using Circulating Tumor Cells
- (2010) Elizabeth A. Punnoose et al. PLoS One
- Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
- (2009) Tetsuya Mitsudomi et al. FEBS Journal
- Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
- (2008) Sharon Barr et al. CLINICAL & EXPERIMENTAL METASTASIS
- Micrometastatic disease in breast cancer: Clinical implications
- (2008) Michail Ignatiadis et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started